FETZIMA

This brand name is authorized in United States. It is also authorized in Canada, UK.

Active ingredients

The drug FETZIMA contains one active pharmaceutical ingredient (API):

1	Milnacipran UNII 371U2ZK31U - LEVOMILNACIPRAN HYDROCHLORIDE
	Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the management of fibromyalgia in patients that are 18 years old or above.
	Read more about Milnacipran

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FETZIMA Extended release capsule	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX17	Milnacipran	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02440970, 02440989, 02440997, 02441004
GB	Medicines & Healthcare Products Regulatory Agency	295082, 295090
US	FDA, National Drug Code	0456-2212, 0456-2220, 0456-2240, 0456-2280